scispace - formally typeset
S

Seung-Mo Hong

Researcher at University of Ulsan

Publications -  383
Citations -  21628

Seung-Mo Hong is an academic researcher from University of Ulsan. The author has contributed to research in topics: Pancreatic cancer & Cancer. The author has an hindex of 53, co-authored 361 publications receiving 17907 citations. Previous affiliations of Seung-Mo Hong include University of Virginia Health System & Johns Hopkins University School of Medicine.

Papers
More filters
Journal ArticleDOI

A comparison of enhancement patterns on dynamic enhanced CT and survival between patients with pancreatic neuroendocrine tumors with and without intratumoral fibrosis.

TL;DR: patients with pancreatic neuroendocrine tumors with fibrosis showed a progressive enhancement pattern and worse overall survival than pNETs without, which showed an early enhancement and wash-out pattern.
Journal ArticleDOI

Primary solid pancreatic tumors: recent imaging findings updates with pathology correlation

TL;DR: The imaging findings of primary solid pancreatic tumors have long been studied and are generally well-established, but a wealth of new information has recently appeared in the literature, including the images of novel or previously seldom-addressed pathological entities as well as atypical Imaging findings of common tumors, both of which are well-correlated with the pathology findings.
Journal ArticleDOI

Distribution pattern of tumor infiltrating lymphocytes and tumor microenvironment composition as prognostic indicators in anorectal malignant melanoma.

TL;DR: TILs have a strong prognostic value in ARMM, and the quantification of TILs and an analysis of the TIL phenotype and infiltration pattern during pathological diagnosis are essential to guide treatment strategies and accurate prognosis.
Journal ArticleDOI

Tumor Budding and Poorly Differentiated Clusters in Small Intestinal Adenocarcinoma.

TL;DR: High-pTB can be used as an adverse prognostic indicator in SIAC patients, especially when patients are in early disease stages, and high-TB/PDC, both in peritumoral and intratumoral localizations, were associated with aggressive behaviors inSIACs.
Journal ArticleDOI

Is Pathologic Near-Total Regression an Appropriate Indicator of a Good Response to Preoperative Chemoradiotherapy Based on Oncologic Outcome of Disease?

TL;DR: Based on differences in the oncologic outcomes between the TR and NTR groups, it might not be suitable to use NTR as an indicator of good response to PCRT together with TR, according to the published literature.